{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Azaserine",
  "nciThesaurus": {
    "casRegistry": "115-02-6",
    "chebiId": "",
    "chemicalFormula": "C5H7N3O4",
    "definition": "A naturally occurring serine derivative diazo compound with antineoplastic properties, Azaserine functions as a purine antagonist and glutamine analogue (glutamine amidotransferase inhibitor) that competitively inhibits pathways in which glutamine is metabolized. An antibiotic and antitumor agent, Azaserine is used in clinical studies as a potential antineoplastic agent.",
    "fdaUniiCode": "87299V3Q9W",
    "identifier": "C289",
    "preferredName": "Azaserine",
    "semanticType": "Antibiotic",
    "subclassOf": [
      "C2158"
    ],
    "synonyms": [
      "AZASERINE",
      "AZS",
      "Azaserine",
      "CL-337",
      "CN 15757",
      "CN-15757",
      "Cl 337",
      "Diazoacetate (Ester) L-Serine",
      "Diazoacetate(ester) L-serine",
      "Diazoacetic Acid Ester with Serine",
      "Diazoacetylserine",
      "L-Azaserine",
      "L-Diazoacetate(ester) serine",
      "L-diazoacetate (ester) serine",
      "L-serine diazoacetate (ester)",
      "O-diazoacetyl-L-serine",
      "P-165",
      "Serine Diazoacetate",
      "o-Diazoacetyl-L-serine"
    ]
  }
}